Tag
US FDA
3 articles
Rubicon Receives 2 US FDA Observations at Pithampur
Rubicon discloses US FDA inspection results for its Pithampur facility, conducted from June 29 to July 3, 2026.
The inspection concluded with a Form 483 containing 2 procedural observations, with no d
Lupin Receives FDA VAI Classification for Somerset Facility
Lupin received FDA Establishment Inspection Report with Voluntary Action Indicated classification for its Somerset, New Jersey manufacturing facility.
The satisfactory inspection outcome confirms regu
Glenmark Receives Six US FDA Goa Plant Observations
Glenmark discloses US FDA inspection at its Goa manufacturing facility from June 22-30, 2026.
Facility received Form 483 with six procedural observations, with no data integrity issues noted.
Company